| HOME >> MEDICINE >> TECHNOLOGY |
6.4.1 Low-Cost Skilled Labor 83
6.4.2 Increase in Generics 83
6.4.3 Product Patent Regime 83
6.4.4 Vertically Integrated Business Model 83
6.4.5 Strategic Partnerships 83
6.5 CMO Market Restraints 84
6.5.1 Increasing Competition from China 84
6.5.2 Time-Consuming Development Periods 84
6.5.3 Need for Robust Execution Strategy 84
6.5.4 Poor Intellectual Property Protection and Regulatory Framework 85
6.5.5 Threat of Counterfeit Medicines Originating from India 85
6.5.6 Varied Compliance With cGMP Guidelines Across the Nation 85
6.5.7 High Effective Tax Rates 85
6.6 Clinical Research Organization (CRO) Market Size and Growth in India 85
6.6.1 Major CRO Locations in India 86
6.6.2 Clinical Trials Registered in 2009 in India 86
6.7 Key Players – Foreign 88
6.7.1 Quintiles 88
6.7.2 Paraxel 88
6.7.3 Pharmaceutical Product Development (PPD) Inc. 89
6.8 Key Players – Domestic 89
6.8.1 SIRO Clinpharm Pvt Ltd 89
6.8.2 Veeda Clinical Research Ltd 90
6.8.3 GVK Biosciences Pvt Ltd 91
6.8.4 Ecron Acunova 92
6.8.5 Synchron Research Services Pvt Ltd 93
6.9 CRO Market Drivers 94
6.9.1 High Risks and Costs Associated With Drug Development 94
6.9.2 Escalating Cost of Clinical Trials 95
6.9.3 Increase in Multinational Sites to Conduct Clinical Trials Will Drive the Clinical Trials Market in India 96
6.9.4 Increased Patient Availability due to Major Diseases 97
6.9.5 Global Increase in the Number of Clinical Trials Conducted 97
6.9.6 Restructuring the R&D 98
6.9.7 Increased Screening Rates During R&D 99
6.9.8 Expiring Patents Pressurize Pharmaceutical Companies to Reduce Costs 99
6.10 CRO Market Restraints 99
6.10.1 Lack of Training for Clinical Trial Professionals 99
6.10.2 Quality of Clini
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |